Family Medicine, Addiction Medicine · Eldorado, IL
NPI
1801076146
Since 2007
Specialty
Family Medicine, Addiction Medicine
Code 207QA0401X
Group practices
3
Medicare group memberships
Hospitals
5
Hospital affiliations
1401 US Highway 45 N
Eldorado, IL, 62930
Phone (618) 273-2951
Groups this clinician bills Medicare through
Medicare paid, 2024
$5,808
174 services
Medicare patients, 2024
107
Average age 69
Drug cost, 2024
$647K
6,961 prescriptions
Company payments, 2025
$905
From 16 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Michael A Blain was code 87428 (infectious agent detection by dna/rna), 76 times for 59 patients. In total Michael A Blain billed 174 services in 11 codes, and Medicare paid $5,808.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-02-05.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 87428 Infectious Agent Detection by DNA/RNA | Office | 76 | 59 | $67.36 | $5,119 |
| 81003 Clinical Chemistry | Office | 50 | 41 | $2.17 | $108 |
| 93005 Electrocardiogram | Office | 20 | 17 | $3.72 | $74.32 |
| 87880 Immunoassay | Office | 17 | 15 | $16.20 | $275 |
By year: 2022 $7,422 for 293 services; 2023 $3,261 for 169 services; 2024 $5,808 for 174 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 87428 Infectious Agent Detection by DNA/RNA | 76 | 59 | $67.36 | $5,119 |
| 81003 Clinical Chemistry | 50 | 41 | $2.17 | $108 |
| 87880 Immunoassay | 17 | 15 | $16.20 | $275 |
Medicare prescription drug claims, 2024
In 2024, the drug Michael A Blain prescribed most often to Medicare patients was Lisinopril, with 322 prescriptions and refills. In total Michael A Blain wrote 6,961 Medicare prescriptions that cost $647K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Lisinopril Generic | 322 | 504 | 62 | $1,229 |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 195 | 195 | 37 | $5,133 |
| Famotidine Generic | 155 | 189 | 32 | $764 |
| Atorvastatin Calcium Generic | 149 | 263 | 29 | $605 |
| Pantoprazole Sodium Generic | 146 | 222 | 26 | $743 |
| Trulicity Dulaglutide | 141 | 141 | 25 | $131K |
| Gabapentin Generic | 139 | 163 | 24 | $1,499 |
| Amlodipine Besylate Generic | 137 | 214 | 27 | $373 |
| Levothyroxine Sodium Generic | 136 | 229 | 25 | $845 |
| Carvedilol Generic | 136 | 224 | 28 | $394 |
| Buprenorphine-Naloxone Buprenorphine Hcl/Naloxone Hcl | 133 | 135 | 18 | $20K |
| Rosuvastatin Calcium Generic | 132 | 174 | 22 | $870 |
| Simvastatin Generic | 130 | 218 | 23 | $546 |
| Metformin Hcl Generic | 129 | 169 | 17 | $338 |
| Omeprazole Generic | 114 | 174 | 21 | $416 |
Brand drugs: 905 claims; generic drugs: 5,979 claims; opioid claims: 362.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Michael A Blain $905 ($905 in general payments such as food, travel and fees) from 16 companies. The largest payer was Alkermes, Inc. with $166.
| Company | Payments | Amount |
|---|---|---|
| Alkermes, Inc. ALKS | 9 | $166 |
| Neurocrine BioSciences, Inc. NBIX | 5 | $105 |
| Axsome Therapeutics, Inc. AXSM | 5 | $96.73 |
| Otsuka America Pharmaceutical, Inc. 4578.T | 4 | $92.82 |
| E.R. Squibb & Sons, L.L.C. BMY | 5 | $85.88 |
| Vanda Pharmaceuticals Inc. VNDA | 3 | $68.92 |
| Janssen Pharmaceuticals, Inc JNJ | 3 | $63.6 |
| Merck Sharp & Dohme LLC MRK | 3 | $57.85 |
| Braeburn Inc. | 2 | $44.56 |
| Novo Nordisk Inc NVO | 1 | $23.9 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.